Profile data is unavailable for this security.
About the company
Sedana Medical AB (publ) is a Sweden-based medical technology company. It develops, markets and sales medical devices and conducts drug development for future projects around AnaConDa technology. The AnaConDa technology delivery enables of volatile anaesthetics to invasively ventilated patients. The products portfolio comprises disposable medical devices AnaConDa for administration of volatile anaesthetics, AnaConDa syringes, FlurAbsorb charcoal filters for removing halogenated hydrocarbon anaesthetic gases, different lines and connectors which can be used to connect the FlurAbsorb filter, adaptors, among others. The Company’s main shareholders are board members, Linc AB and Magiola Consulting AB.
- Revenue in SEK (TTM)197.61m
- Net income in SEK-40.65m
- Incorporated2004
- Employees117.00
- LocationSedana Medical AB (publ)Vendevagen 89DANDERYD 182 32SwedenSWE
- Phone+46 812405200
- Fax+46 812405296
- Websitehttps://sedanamedical.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nanexa AB | 10.58m | -39.06m | 601.56m | 15.00 | -- | 7.50 | -- | 56.88 | -0.2644 | -0.2644 | 0.0694 | 0.4874 | 0.0972 | 24.67 | 1.54 | 813,538.40 | -35.91 | -37.21 | -42.59 | -44.95 | 69.56 | 93.79 | -369.29 | -355.05 | 2.07 | -21.98 | 0.2165 | -- | -16.93 | 70.11 | 67.40 | -- | 21.42 | -- |
| BioPorto A/S | 52.02m | -123.49m | 693.17m | 48.00 | -- | 12.72 | -- | 13.33 | -0.1973 | -0.1973 | 0.083 | 0.0774 | 0.4132 | 2.55 | 4.69 | 962,131.60 | -98.08 | -65.22 | -133.92 | -88.74 | 63.90 | 64.15 | -237.40 | -222.22 | 1.71 | -- | 0.1916 | -- | 17.07 | 6.36 | -21.15 | -- | -20.56 | -- |
| OssDsign AB | 180.16m | -50.99m | 704.69m | 32.00 | -- | 2.27 | -- | 3.91 | -0.5493 | -0.5493 | 2.06 | 2.80 | 0.5109 | 0.3672 | 6.95 | 5,629,938.00 | -14.46 | -25.42 | -16.05 | -28.59 | 96.29 | 85.57 | -28.30 | -82.42 | 6.33 | -13.77 | 0.0044 | -- | 34.51 | 48.59 | -2.68 | -- | 24.28 | -- |
| Senzime AB (publ) | 89.71m | -120.62m | 710.61m | 50.00 | -- | 2.04 | -- | 7.92 | -0.8672 | -0.8672 | 0.6394 | 2.22 | 0.234 | 1.73 | 5.99 | 1,794,120.00 | -31.47 | -35.09 | -34.04 | -37.52 | 41.86 | 8.75 | -134.46 | -400.65 | 4.30 | -7.70 | 0.0399 | -- | 63.55 | 54.18 | 11.50 | -- | 40.12 | -- |
| Omda AS | 442.41m | -28.20m | 804.30m | 260.00 | -- | 25.36 | 29.13 | 1.82 | -1.51 | -1.51 | 23.59 | 1.63 | 0.6793 | 26.59 | 21.70 | 1,772,075.00 | -4.33 | -5.14 | -5.39 | -6.63 | 93.69 | 91.09 | -6.37 | -10.32 | 0.6483 | 0.5281 | 0.9359 | -- | 3.45 | 15.80 | -163.95 | -- | -15.57 | -- |
| Gentian Diagnostics ASA | 160.71m | 39.85m | 821.79m | 63.00 | 20.92 | 4.37 | 17.03 | 5.11 | 2.73 | 2.73 | 11.07 | 13.10 | 0.8181 | 1.63 | 7.83 | 2,738,365.00 | 20.29 | -2.99 | 22.99 | -3.36 | 55.06 | 44.66 | 24.80 | -5.84 | 4.16 | -- | 0.0094 | -- | 12.52 | 25.96 | 525.37 | -- | 22.08 | -- |
| Optomed Oyj | 184.77m | -61.07m | 904.22m | 112.00 | -- | 3.85 | -- | 4.89 | -0.2915 | -0.2915 | 0.8803 | 1.03 | 0.5847 | 2.40 | 5.47 | 151,147.80 | -19.33 | -14.59 | -23.47 | -17.41 | 64.64 | 65.60 | -33.05 | -31.36 | 1.60 | -20.89 | 0.1221 | -- | -0.3974 | 0.084 | -22.72 | -- | 8.10 | -- |
| Nexstim Oyj | 106.99m | -3.01m | 966.15m | 40.00 | -- | 28.47 | 136.93 | 9.03 | -0.042 | -0.042 | 1.47 | 0.4426 | 0.8553 | 0.5613 | 4.66 | 251,616.80 | -2.40 | -12.40 | -4.17 | -20.76 | 94.36 | 95.09 | -2.81 | -16.29 | 1.08 | 0.7835 | 0.6002 | -- | 20.55 | 21.14 | 32.79 | -- | 15.13 | -- |
| Sedana Medical AB (publ) | 197.61m | -40.65m | 990.39m | 117.00 | -- | 1.09 | -- | 5.01 | -0.4092 | -0.4092 | 1.99 | 9.14 | 0.2012 | 1.46 | 9.47 | 2,670,406.00 | -4.14 | -4.90 | -4.34 | -5.16 | 70.47 | 68.32 | -20.57 | -30.26 | 3.28 | -21.90 | 0.0045 | -- | 16.17 | 20.06 | 82.09 | -- | 26.45 | -- |
| ADDvise Group AB (publ) | 1.62bn | 4.30m | 1.04bn | 615.00 | 19.97 | 0.943 | 9.38 | 0.6417 | 0.0864 | 0.0864 | 3.44 | 1.83 | 0.5167 | 7.91 | 4.96 | 2,534,790.00 | 0.1399 | 3.41 | 0.174 | 4.28 | 39.91 | 46.52 | 0.2708 | 6.06 | 0.7562 | 1.62 | 0.5251 | 0.4389 | 21.68 | 36.71 | -13.04 | 85.85 | 52.63 | -- |
| C Rad AB | 457.70m | 23.25m | 1.05bn | 107.00 | 46.08 | 3.03 | 30.90 | 2.29 | 0.6922 | 0.6922 | 13.58 | 10.53 | -- | -- | -- | 4,623,273.00 | -- | 8.44 | -- | 11.73 | 51.45 | 45.00 | 5.08 | 8.28 | 2.98 | 3.31 | 0.0252 | 0.00 | 10.45 | 17.96 | 58.88 | -- | -9.15 | -- |
| Paxman AB (publ) | 295.08m | 4.92m | 1.06bn | 142.00 | 164.69 | 2.47 | 42.88 | 3.58 | 0.2757 | 0.2757 | 14.26 | 18.38 | 0.8486 | 3.45 | 4.71 | 2,810,305.00 | 1.37 | 0.8426 | 1.60 | 1.20 | 67.34 | 68.75 | 1.61 | 0.7966 | 4.07 | 1.71 | 0.0245 | 0.00 | 20.41 | 24.30 | 382.55 | 70.92 | -3.73 | -- |
| BICO Group AB | 1.51bn | -1.26bn | 1.19bn | 586.00 | -- | 0.6688 | -- | 0.7874 | -17.83 | -9.68 | 21.34 | 25.67 | 0.3269 | 3.30 | 3.65 | 2,074,793.00 | -27.41 | -- | -35.79 | -- | 36.91 | -- | -83.83 | -- | 1.13 | -- | 0.4174 | -- | -3.19 | -- | 88.56 | -- | -- | -- |
| Surgical Science Sweden AB | 975.04m | 69.83m | 1.23bn | 328.00 | 17.67 | 0.2869 | 8.48 | 1.27 | 1.37 | 1.37 | 19.11 | 84.27 | 0.2051 | 1.72 | 7.09 | 3,558,537.00 | 1.47 | 3.91 | 1.55 | 4.18 | 66.61 | 68.94 | 7.16 | 21.55 | 3.44 | -- | 0.0004 | 0.00 | 0.1398 | 54.17 | -43.73 | 59.89 | 39.76 | -- |
| Stille AB | 552.55m | 40.41m | 1.31bn | 208.00 | 32.44 | 1.89 | 14.80 | 2.37 | 4.50 | 4.50 | 62.09 | 77.10 | 0.531 | 1.55 | 7.66 | 3,891,176.00 | 3.88 | 6.20 | 4.55 | 7.11 | 52.45 | 47.21 | 7.31 | 9.48 | 1.87 | -- | 0.00 | 16.29 | 93.27 | 29.47 | 118.44 | 20.53 | 13.88 | -- |
| Genovis AB | 116.63m | 21.19m | 1.35bn | 36.00 | 63.41 | 5.13 | 41.92 | 11.58 | 0.3225 | 0.3225 | 1.78 | 3.99 | 0.3404 | -- | -- | 3,644,719.00 | 6.18 | 15.62 | 6.57 | 17.56 | 90.28 | 88.86 | 18.16 | 25.11 | -- | -- | 0.2171 | 0.00 | -17.62 | 16.58 | -46.48 | 28.08 | -1.42 | -- |
Data as of Feb 10 2026. Currency figures normalised to Sedana Medical AB (publ)'s reporting currency: Swedish Krona SEK
30.23%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Lannebo Kapitalf�rvaltning AB (Sweden)as of 31 Dec 2025 | 7.48m | 7.53% |
| Premier Fund Managers Ltd.as of 20 Oct 2025 | 4.97m | 5.00% |
| Swedbank Robur Fonder ABas of 30 Oct 2024 | 4.67m | 4.70% |
| Lancelot Asset Management ABas of 31 Dec 2024 | 2.85m | 2.87% |
| AMF Fonder ABas of 31 Dec 2024 | 2.49m | 2.51% |
| Highclere International Investors LLPas of 31 Mar 2025 | 2.27m | 2.29% |
| Handelsbanken Fonder ABas of 31 Jan 2026 | 1.98m | 2.00% |
| Skandia Investment Management ABas of 28 Nov 2025 | 1.61m | 1.62% |
| AXA Investment Managers (Paris) SAas of 30 Sep 2025 | 1.11m | 1.12% |
| SEB Funds ABas of 31 Dec 2025 | 603.30k | 0.61% |
More ▼
Data from 31 Dec 2024 - 02 Feb 2026Source: FactSet Research Systems Inc.
